Legal Representation
Attorney
Stacy L. Emhoff
USPTO Deadlines
Next Deadline
1503 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20240312)
Due Date
March 12, 2030
Grace Period Ends
September 12, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
41 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Mar 12, 2024 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Mar 12, 2024 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Feb 1, 2024 | DP1B | I | 1(B) BASIS DELETED; PROCEED TO REGISTRATION | Loading... |
| Dec 5, 2023 | IUCN | S | NOTICE OF ALLOWANCE CANCELLED | Loading... |
| Feb 1, 2024 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Dec 5, 2023 | EPPA | I | TEAS POST PUBLICATION AMENDMENT RECEIVED | Loading... |
| Aug 22, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jun 27, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jun 27, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jun 7, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| May 23, 2023 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| May 16, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| May 15, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| May 14, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| May 14, 2023 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED | Loading... |
| May 14, 2023 | XELG | O | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | Loading... |
| May 14, 2023 | XELR | I | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | Loading... |
| Feb 14, 2023 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Feb 14, 2023 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Feb 14, 2023 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Dec 22, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Dec 22, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Dec 19, 2022 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Oct 27, 2022 | ERSI | I | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | Loading... |
| May 17, 2022 | GNS2 | O | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | Loading... |
| May 17, 2022 | GNSI | S | INQUIRY TO SUSPENSION E-MAILED | Loading... |
| May 17, 2022 | CNSI | R | SUSPENSION INQUIRY WRITTEN | Loading... |
| May 13, 2022 | RCCK | S | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | Loading... |
| Sep 21, 2021 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
| Sep 21, 2021 | GNSL | S | LETTER OF SUSPENSION E-MAILED | Loading... |
| Sep 21, 2021 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| Aug 17, 2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Aug 16, 2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Aug 16, 2021 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Feb 17, 2021 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Feb 17, 2021 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Feb 17, 2021 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Feb 12, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Nov 4, 2020 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Nov 3, 2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Sep 28, 2020 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations and substances for monoclonal antibody therapies and treatments; Monoclonal antibody therapies for therapeutic purposes, being pharmaceutical preparations for the treatment of cancer, autoimmune diseases, inflammatory conditions, allergies and allergic conditions, hypersensitivity reactions, infections, organ transplant rejection, tissue transplant rejection, cardiovascular diseases, neurological disorders, degenerative disorders, metabolic disorders, dermatological diseases; Preparations and substances for medical and pharmaceutical use comprising monoclonal antibodies and/or derivatives thereof for treatment of cancer, leukemia, lymphomas, inflammatory diseases, immunological diseases and other pathologies, treatable or improvable through use of antibodies that bind to, activate or block the target antigens; Monoclonal antibodies for medical treatment and for diagnostics to bind or mask biological molecules in blood, serum plasma or tissue; Blood for medical purposes; Blood plasma
Class 035
Business administrative services for medical referrals to medical specialists; Maintaining a registry of blood stem cell donors and bone marrow donors to facilitate bone marrow, organ, and blood stem cell transplant services for others
Class 039
Arranging of passenger transportation services for patients who need treatment by medical specialists
Class 040
Cryopreservation services; Cryopreservation of stem cell, bone marrow and cell products, donor blood and pharmaceutical substances
Class 042
Medical research services, namely, the carrying out of and coordination of pharmacological studies for third parties to determine if a research topic is worth pursuing by conducting preparatory experiments on stem cells, monoclonal antibodies, mRNA samples and on living organs; Medical research services, namely, the carrying out of and coordination of studies for medical treatment for third parties to assess planned treatments for desired effects and unwanted side effects by conducting medical tests, conducting diagnosis, collecting anamnesis data, and monitoring individuals for wanted effects and unwanted side effects of a proposed medical treatment, all of the foregoing for medical research purposes
Class 043
Services of a travel agency, namely, making hotel reservations for stem cell donors, bone marrow donors and patients as a service for third parties
Class 044
Physician services; Medical clinics; Oncology clinic, namely, radiation oncology services; Providing medical consultation regarding the special medical treatment needs of patients and providing medical advice regarding what medical specialists are needed for that medical treatment; medical consultation in the field of matching third party stem cell donors who are medically prepared for donating stem cells with stem cell receptors; Medical services, namely, the removal and collection of human cells from others that are sent to third parties for processing; Medical services, namely, the coordination of the stem cell donation with stem cell donors and stem cell recipients; Performing apheresis blood collection for the collection of stem cells for third parties
Class 045
Providing case management services, namely, coordinating medical services for patients who need treatment by medical specialists
Additional Information
Design Mark
The mark consists of a red shape and an orange shape that are positioned to look like a twisted loop.
Color Claim
The color(s) red and orange is/are claimed as a feature of the mark.
Classification
International Classes
005
035
039
040
042
043
044
045